Belimumab for systemic lupus erythematosus - Focus on lupus nephritis

In recent years, advances in the treatment and management of patients with systemic lupus erythematosus (SLE) have improved their life expectancy and quality of life. However, lupus nephritis (LN) still represents a major life-threatening complication of the disease. Belimumab (BEL), a fully human m...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Marlene Plüß (Autor), Silvia Piantoni (Autor), Björn Tampe (Autor), Alfred H. J. Kim (Autor), Peter Korsten (Autor)
Format: Knjiga
Izdano: Taylor & Francis Group, 2022-11-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno